Co-Funded Projects
Alex's Lemonade Stand Foundation is proud to partner with nearly 20 different childhood cancer charities to bring us closer to cures. Together, we are supporting the most cutting-edge research in the fight against childhood cancer. View projects supported in collaboration with our charity partners below!
| Project Title | Institution | Co-Funder(s) |
|---|---|---|
| Drugging MYCN | Children’s Hospital of Philadelphia | Cure4Cam Childhood Cancer Foundation, Kate's Cause, Sammy’s Superheroes Foundation, The Catherine Elizabeth Blair Memorial Foundation, Connor’s Heroes Foundation |
| Drugging MYCN | Children’s Hospital of Philadelphia | Cure4Cam Childhood Cancer Foundation, Kate's Cause, Sammy’s Superheroes Foundation, The Catherine Elizabeth Blair Memorial Foundation, Connor’s Heroes Foundation |
| Drugging MYCN | Children’s Hospital of Philadelphia | Cure4Cam Childhood Cancer Foundation, Kate's Cause, Sammy’s Superheroes Foundation, The Catherine Elizabeth Blair Memorial Foundation, Connor’s Heroes Foundation |
| Drugging MYCN | Children’s Hospital of Philadelphia | Cure4Cam Childhood Cancer Foundation, Kate's Cause, Sammy’s Superheroes Foundation, The Catherine Elizabeth Blair Memorial Foundation, Connor’s Heroes Foundation |
| Drugging MYCN | Children’s Hospital of Philadelphia | Cure4Cam Childhood Cancer Foundation, Kate's Cause, Sammy’s Superheroes Foundation, The Catherine Elizabeth Blair Memorial Foundation, Connor’s Heroes Foundation |
| Assessing Clonal Fitness and Mechanisms of Clonal Evolution in FPD-MN | Memorial Sloan-Kettering Cancer Center | The RUNX1 Research Program |
| Modeling familial platelet disorder associated RUNX1 mutations in mice | University of Massachusetts Medical School | The RUNX1 Research Program |
| Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells | Stanford University School of Medicine | Cure4Cam Childhood Cancer Foundation, Tap Cancer Out, Kate's Cause |
| Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells | Stanford University School of Medicine | Cure4Cam Childhood Cancer Foundation, Tap Cancer Out, Kate's Cause |
| Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells | Stanford University School of Medicine | Cure4Cam Childhood Cancer Foundation, Tap Cancer Out, Kate's Cause |
